STAT6 and neoplasm: In this system, CEL could inhibit the STAT6 pathway and repolarize tumor‐associated macrophages from the M2 phenotype to the M1 phenotype, thus alleviating tumor immunosuppression, and exerting a synergistic and potentiating effect with LY2157299, which showed a good therapeutic effect on glioma.